MX2016012903A - Metodos y composiciones para la modificacion de la percepcion sensorial. - Google Patents

Metodos y composiciones para la modificacion de la percepcion sensorial.

Info

Publication number
MX2016012903A
MX2016012903A MX2016012903A MX2016012903A MX2016012903A MX 2016012903 A MX2016012903 A MX 2016012903A MX 2016012903 A MX2016012903 A MX 2016012903A MX 2016012903 A MX2016012903 A MX 2016012903A MX 2016012903 A MX2016012903 A MX 2016012903A
Authority
MX
Mexico
Prior art keywords
screening
trpa1v1
trp channels
trpv1
compositions
Prior art date
Application number
MX2016012903A
Other languages
English (en)
Inventor
Lin Yakang
Tatachar Sreekrishna Koti
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2016012903A publication Critical patent/MX2016012903A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Compuestos y métodos para modificar la percepción sensorial asociada con los receptores sensoriales transitorios TRPA1, TRPV1 y TRPA1V1. Un método para analizar compuestos para la modulación de TRPA1, TRPV1 y/o TRPA1V1. Composiciones que comprenden agonistas o antagonistas de TRPA1V1, para modificar la percepción sensorial de las composiciones.
MX2016012903A 2014-04-01 2015-03-24 Metodos y composiciones para la modificacion de la percepcion sensorial. MX2016012903A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461973566P 2014-04-01 2014-04-01
PCT/US2015/022170 WO2015153184A1 (en) 2014-04-01 2015-03-24 Method for screening trp channels

Publications (1)

Publication Number Publication Date
MX2016012903A true MX2016012903A (es) 2016-12-07

Family

ID=52815337

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012903A MX2016012903A (es) 2014-04-01 2015-03-24 Metodos y composiciones para la modificacion de la percepcion sensorial.

Country Status (6)

Country Link
US (3) US9427415B2 (es)
EP (1) EP3126831A1 (es)
CN (1) CN106537149A (es)
CA (2) CA3017423A1 (es)
MX (1) MX2016012903A (es)
WO (1) WO2015153184A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018007441A (es) * 2015-12-18 2018-11-09 Procter & Gamble Sintesis de derivados de ester de ciclohexano utiles como agentes de percepcion en productos de consumo.
EP3515215A4 (en) * 2016-09-23 2020-09-09 Sentiens, LLC MEANS AND METHODS OF MODULATING THE SENSORY EFFECT OF TOBACCO OR VEGETABLE SMOKE
WO2018081189A1 (en) 2016-10-25 2018-05-03 The Procter & Gamble Company Fibrous structures
WO2018081191A1 (en) 2016-10-25 2018-05-03 The Procter & Gamble Company Differential pillow height fibrous structures
CN106822096A (zh) * 2017-01-22 2017-06-13 新乡医学院 治疗动脉粥样硬化的药物组合物以及该药物组合物的应用
MX2022001186A (es) * 2019-07-31 2022-05-11 Sea4Us Biotecnologia E Recursos Marinhos Lda Compuestos analogos de nitenina y su uso en el tratamiento de dolor cronico y agudo.
JPWO2021039269A1 (es) * 2019-08-30 2021-03-04
WO2023242696A1 (en) * 2022-06-12 2023-12-21 Buzzelet Development And Technologies Ltd. Modulation of a physiological function via modulation of activation of a transient receptor potential channel receptor

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0211205A (ja) * 1988-06-29 1990-01-16 Kawasaki Steel Corp 熱間圧延機の板厚制御方法
JP4444493B2 (ja) 1997-08-20 2010-03-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア カプサイシン受容体およびカプサイシン受容体関連ポリペプチドをコードする核酸配列ならびにその使用
US6482611B1 (en) 1999-09-23 2002-11-19 Neurogen Corporation Human capsaicin receptor and uses thereof
AU1607701A (en) * 1999-11-15 2001-05-30 J. Manheimer, Inc. Flavor freshness enhancers
US6780443B1 (en) * 2000-02-04 2004-08-24 Takasago International Corporation Sensate composition imparting initial sensation upon contact
US6455278B1 (en) 2000-02-08 2002-09-24 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding human vanilloid receptor VR3
EP1313768B1 (de) 2000-09-02 2008-02-06 Grünenthal GmbH Antisense oligonukleotide gegen vr 1
DE10257421A1 (de) 2002-12-09 2004-07-08 Grünenthal GmbH Regulatorische Elemente im 5'-Bereich des VR1-Gens
US7465581B2 (en) 2002-12-18 2008-12-16 The Scripps Research Institute ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons
US20050266435A1 (en) 2004-03-09 2005-12-01 David Hackos VR1 receptors and uses thereof
WO2007098252A2 (en) * 2006-02-21 2007-08-30 Irm Llc Methods and compositions for treating hyperalgesia
US7897358B2 (en) * 2007-03-07 2011-03-01 Janssen Pharmaceutica N.V. Canine transient receptor potential V2 (cTRPV2) and methods of screening for TRPV2 channel modulators
EP2306902A4 (en) * 2008-07-11 2011-08-10 Sru Biosystems Inc METHOD FOR IDENTIFYING ION CHANNEL MODULATORS
US8962057B2 (en) 2009-04-29 2015-02-24 The Procter & Gamble Company Methods for improving taste and oral care compositions with improved taste
DE102009027744A1 (de) * 2009-07-15 2011-01-20 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Prekursor-Verbindungen von Süßrezeptor-Antagonisten zur Prävention oder Behandlung von Krankheiten
US9044429B2 (en) 2010-01-15 2015-06-02 The Gillette Company Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof
JP5669421B2 (ja) * 2010-03-30 2015-02-12 株式会社マンダム アルコール刺激抑制物質の評価方法
US20130315843A1 (en) 2012-05-25 2013-11-28 The Procter & Gamble Company Composition for reduction of trpa1 and trpv1 sensations

Also Published As

Publication number Publication date
US20180049960A1 (en) 2018-02-22
US20160331659A1 (en) 2016-11-17
EP3126831A1 (en) 2017-02-08
CN106537149A (zh) 2017-03-22
US9427415B2 (en) 2016-08-30
WO2015153184A8 (en) 2016-12-22
US20150272907A1 (en) 2015-10-01
CA3017423A1 (en) 2015-10-08
WO2015153184A1 (en) 2015-10-08
CA2941903A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
MX2016012903A (es) Metodos y composiciones para la modificacion de la percepcion sensorial.
HRP20200201T1 (hr) Spojevi i sastavi za moduliranje aktivnosti mutantne egfr kinaze
EP3655616A4 (en) BOTTOM OF HOLE OSCILLATION DEVICE
EP3134102A4 (en) Superagonists, partial agonists and antagonists of interleukin-2
HK1226064A1 (zh) 作為trpm8拮抗劑的氮雜螺衍生物
HRP20200133T1 (hr) Novi supstituirani derivati cijanoindolina kao inhibitori nik
SI3172232T1 (sl) Na mesto usmerjena mutageneza protiteles TREM-1 za zmanjšanje viskoznosti
GB201717974D0 (en) Modified receptors
IL275139A (en) NKG2D DARIC receptors
HK1257927A1 (zh) 含有六元氮雜雜環的δ阿片受體調節化合物、其使用和製備方法
EA201890981A1 (ru) Новые гетероциклические антиэстрогены
IL271808A (en) Novel mutated azaindoline derivatives as NIK inhibitors
EP3178536A4 (en) Defoamer oil compound, production method therefor, and defoamer composition
IL256496B (en) 5–ht2 blockers
EP3454845A4 (en) ADRENERGIC RECEPTOR MODULATION COMPOUNDS AND METHODS OF USE THEREOF
MX2017000519A (es) Derivados de azaspiro(4.5)decano sustituido.
IL248807B (en) Kv1.3 potassium channel antagonists